The hiv viral load and early infant diagnosis market is projected to grow from USD 6,795.0 million in 2026 to USD 15,939.3 million by 2036, at a CAGR of 8.9%. PCR viral load assays will dominate with a 54.0% market share, while routine viral load monitoring will lead the applications segment with a 48.0% share.